New study looks at best acyclovir dose for obese patients with brain infection
NCT ID NCT05127395
First seen Mar 23, 2026 · Last updated May 25, 2026 · Updated 8 times
Summary
This study looked back at medical records of 50 obese adults (BMI over 30) who were treated for HSV encephalitis, a serious brain infection, with the drug acyclovir. The goal was to see if using ideal body weight or adjusted body weight to calculate the dose changed the chance of dying in the hospital. The study did not test a new treatment but aimed to gather information to improve dosing guidelines.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HSV ENCEPHALITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Methodist Charlton Medical Center
Dallas, Texas, 75237, United States
Conditions
Explore the condition pages connected to this study.